A 2009 report published in the International Urogynecology Journal shows clearly that the risk for bacterial infection is dramatically increased with the use of transvaginal mesh, a popular synthetic substitute for human tissue used in surgical repair following pelvic organ prolapse and other ailments.  While transvaginal mesh has previously been found to cause vaginal mesh erosion at a rate of between 10 and 20%, only little research has been conducted on the connection between TVM use and increased risk for infection.

The study team, lead by Astrid Vollebregt, evaluated the amount of bacteria on the transvaginal mesh implants of 64 consequtive women,[1] and “In 56 (83.6%) [transvaginal mesh] implants, a positive culture with vaginal bacteria was found”[2].  Clearly, this rate of complication is exceedingly high.

While this study does not on its own prove that transvaginal mesh use creates an increased risk for bacterial infection, it may be used as a springboard for future research on this topic.  And further, this article may be used in a transvaginal mesh lawsuit to help illustrate the scope of the negative side-effects caused by transvaginal mesh use.

In fact, many transvaginal mesh lawsuits are currently being filed due to the fact that several transvaginal mesh manufacturers have failed to adequately warn users about risks well-documented to be associated with TVM, such as vaginal mesh erosion.  If you or a loved one used transvaginal mesh and experienced vaginal mesh erosion or mesh-related infection, you may be entitled to significant financial compensation for your injuries.

For a free case consultation, contact our team of transvaginal mesh lawyers by phone at (855) 452-5529 or by e-mail at justinian@dangerousdrugs.us.

Our Transvaginal Mesh Lawsuit Information page is a great place to start if you have additional questions about Transvaginal Mesh.  We are here to help!

[1] Vollebregt, A. et al. “Bacterial colonisation of collagen-coated polypropylene vaginal mesh: are additional intraoperative sterility procedures useful?” Int Urogynecol J (2009) 20:1345–1351

[2] Ibid.